Oncotarget

Vol 9, No 59

July 31, 2018

View Archive »

Order a Reprint

About The Cover

The cover for issue 59 of Oncotarget features Figure 4, "The expression of AGR2 in metastatic lesions," by Kamal, et al.

Table of Contents

Research Papers

Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing

Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing

https://doi.org/10.18632/oncotarget.25764

Lilla Ozgyin, Attila Horvath,  and Balint Laszlo Balint
31312-31329
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process

Association of Notch-1, osteopontin and stem-like cells in ENU-glioma malignant process

https://doi.org/10.18632/oncotarget.25808

Susana Bulnes, Garazi Bermúdez,  and José Vicente Lafuente
31330-31341
Abstract  |  PDF  |  HTML  |  Order a Reprint

A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells

A short-chain fatty acid, propionate, enhances the cytotoxic effect of cisplatin by modulating GPR41 signaling pathways in HepG2 cells

https://doi.org/10.18632/oncotarget.25809

Mamiko Kobayashi, Daisuke Mikami, Junsuke Uwada, Takashi Yazawa, Kazuko Kamiyama, Hideki Kimura, Takanobu Taniguchi,  and Masayuki Iwano
31342-31354
Abstract  |  PDF  |  HTML  |  Order a Reprint

Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis

Absence of formyl peptide receptor 1 causes endometriotic lesion regression in a mouse model of surgically-induced endometriosis

https://doi.org/10.18632/oncotarget.25823

Roberta Fusco, Ramona D’amico, Marika Cordaro, Enrico Gugliandolo, Rosalba Siracusa, Alessio Filippo Peritore, Rosalia Crupi, Daniela Impellizzeri, Salvatore Cuzzocrea,  and Rosanna Di Paola
31355-31366
Abstract  |  PDF  |  HTML  |  Order a Reprint

STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models

STK405759 as a combination therapy with bortezomib or dexamethasone, in in vitro and in vivo multiple myeloma models

https://doi.org/10.18632/oncotarget.25825

Gabriela Rozic, Lena Paukov, Ziv Cohen, Irit Shapira, Adrian Duek, Ohad Bejamini, Abraham Avigdor, Arnon Nagler, Igor Koman,  and Merav Leiba
31367-31379
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3

Optical in vivo imaging detection of preclinical models of gut tumors through the expression of integrin αVβ3

https://doi.org/10.18632/oncotarget.25826

Giulia Marelli, Roberta Avigni, Paola Allavena, Cecilia Garlanda, Alberto Mantovani, Andrea Doni,  and Marco Erreni
31380-31396
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma

The combination of epigenetic drugs SAHA and HCI-2509 synergistically inhibits EWS-FLI1 and tumor growth in Ewing sarcoma

https://doi.org/10.18632/oncotarget.25829

Daniel Jose García-Domínguez, Lourdes Hontecillas-Prieto, Pablo Rodríguez-Núñez, Guillem Pascual-Pasto, Monica Vila-Ubach, Rosa García-Mejías, María José Robles, Oscar M. Tirado, Jaume Mora, Angel M. Carcaboso,  and Enrique de Álava
31397-31410
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies

Topoisomerase I inhibitor, irinotecan, depletes regulatory T cells and up-regulates MHC class I and PD-L1 expression, resulting in a supra-additive antitumor effect when combined with anti-PD-L1 antibodies

https://doi.org/10.18632/oncotarget.25830

Toshiki Iwai, Masamichi Sugimoto, Daiko Wakita, Keigo Yorozu, Mitsue Kurasawa,  and Kaname Yamamoto
31411-31421
Abstract  |  PDF  |  HTML  |  Order a Reprint

Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo

Development and evaluation of a novel antibody-photon absorber conjugate reveals the possibility of photoimmunotherapy-induced vascular occlusion during treatment in vivo

https://doi.org/10.18632/oncotarget.25831

Yuya Isoda, Wen Piao, Eri Taguchi, Junko Iwano, Shigeki Takaoka, Aiko Uchida, Kiyomi Yoshikawa, Junichi Enokizono, Emi Arakawa, Kazuma Tomizuka, Yasuhisa Shiraishi,  and Kazuhiro Masuda
31422-31431
Abstract  |  PDF  |  HTML  |  Order a Reprint

CCL17/TARC and CCR4 expression in Merkel cell carcinoma

CCL17/TARC and CCR4 expression in Merkel cell carcinoma

https://doi.org/10.18632/oncotarget.25836

Kashif Rasheed, Ibrahim Abdulsalam, Silje Fismen, Øystein Grimstad, Baldur Sveinbjørnsson,  and Ugo Moens
31432-31447
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer

Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer

https://doi.org/10.18632/oncotarget.25837

Mariko Tsukagoshi, Satoshi Wada, Seiko Hirono, Shintaro Yoshida, Erica Yada, Tetsuro Sasada, Ken Shirabe, Hiroyuki Kuwano,  and Hiroki Yamaue
31448-31458
Abstract  |  PDF  |  HTML  |  Order a Reprint

High AGR2 protein is a feature of low grade endometrial cancer cells

High AGR2 protein is a feature of low grade endometrial cancer cells

https://doi.org/10.18632/oncotarget.25838

Areege Kamal, Anthony Valentijn, Roger Barraclough, Philip Rudland, Nihad Rahmatalla, Pierre Martin-Hirsch, Helen Stringfellow, Shandya B. Decruze,  and Dharani K. Hapangama
31459-31472
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma

Combination of electroporation delivered metabolic modulators with low-dose chemotherapy in osteosarcoma

https://doi.org/10.18632/oncotarget.25843

Kheshwant S. Gill, Philana Fernandes, Brian Bird, Declan M. Soden,  and Patrick F. Forde
31473-31489
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T

Chemical exchange saturation transfer MRI to assess cell death in breast cancer xenografts at 7T

https://doi.org/10.18632/oncotarget.25844

Jonathan Klein, Wilfred W. Lam, Gregory J. Czarnota,  and Greg J. Stanisz
31490-31501
Abstract  |  PDF  |  HTML  |  Order a Reprint

Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content

Molecular profiling of colorectal tumors stratified by the histological tumor-stroma ratio - Increased expression of galectin-1 in tumors with high stromal content

https://doi.org/10.18632/oncotarget.25845

Tessa P. Sandberg, Jan Oosting, Gabi W. van Pelt, Wilma E. Mesker, Rob A.E.M. Tollenaar,  and Hans Morreau
31502-31515
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer

Interaction between N-cadherin and decoy receptor-2 regulates apoptosis in head and neck cancer

https://doi.org/10.18632/oncotarget.25846

Phuong Thao Nguyen, Dung Nguyen, Chanbora Chea, Mutsumi Miyauchi, Makiko Fujii,  and Takashi Takata
31516-31530
Abstract  |  PDF  |  HTML  |  Order a Reprint

The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation

The E3 ubiquitin ligase HERC1 controls the ERK signaling pathway targeting C-RAF for degradation

https://doi.org/10.18632/oncotarget.25847

Taiane Schneider, Arturo Martinez-Martinez, Monica Cubillos-Rojas, Ramon Bartrons, Francesc Ventura,  and Jose Luis Rosa
31531-31548
Abstract  |  PDF  |  HTML  |  Order a Reprint

Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells

Deep analysis of acquired resistance to FGFR1 inhibitor identifies MET and AKT activation and an expansion of AKT1 mutant cells

https://doi.org/10.18632/oncotarget.25862

Pol Gimenez-Xavier, Eva Pros, Ana Aza, Sebastian Moran, Raul Tonda, Anna Esteve-Codina, Marc Dabad,  and Montse Sanchez-Cespedes
31549-31558
Abstract  |  PDF  |  HTML  |  Supplementary Information  |  Order a Reprint

Corrections

Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB

Correction: S100A9+ MDSC and TAM-mediated EGFR-TKI resistance in lung adenocarcinoma: the role of RELB

https://doi.org/10.18632/oncotarget.25943

Po-Hao Feng, Chih-Teng Yu, Kuan-Yuan Chen, Ching-Shan Luo, Shen Ming Wu, Chien-Ying Liu, Lu Wei Kuo, Yao-Fei Chan, Tzu-Tao Chen, Chih-Cheng Chang, Chun-Nin Lee, Hsiao-Chi Chuang, Chiou-Feng Lin, Chia-Li Han, Wei-Hwa Lee,  and Kang-Yun Lee
31559-31559
Correction  |  PDF


Copyright © 2018 Impact Journals, LLC
Impact Journals is a registered trademark of Impact Journals, LLC